The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Low frequency KRAS G12/13 mutations in urine cell-free (cf) DNA from patients with BRAF V600E-mutant advanced cancers.
 
Filip Janku
Research Funding - Biocartis; Foundation Medicine; Trovagene
 
Cecile Rose T. Vibat
Employment - Trovagene
 
Gerald Steven Falchook
Employment - HealthONE; Sarah Cannon Research Institute
Research Funding - ARMO BioSciences; AstraZeneca; Celgene; EMD Serono; Genmab; GlaxoSmithKline; Incyte; Kolltan Pharmaceuticals; MedImmune; Millennium; Novartis; Vegenics
Patents, Royalties, Other Intellectual Property - Handbook of Targeted Cancer Therapy
Travel, Accommodations, Expenses - EMD Serono; Millennium; Sarah Cannon Research Institute
 
Helen J. Huang
No Relationships to Disclose
 
David S. Hong
No Relationships to Disclose
 
Sarina Anne Piha-Paul
No Relationships to Disclose
 
Vivek Subbiah
No Relationships to Disclose
 
Nishma M. Ramzanali
No Relationships to Disclose
 
Saege Hancock
Employment - Trovagene
 
Aung Naing
No Relationships to Disclose
 
Daniel D. Karp
No Relationships to Disclose
 
Giovanni Nitti
No Relationships to Disclose
 
Goran Cabrilo
No Relationships to Disclose
 
Rajyalakshmi Luthra
No Relationships to Disclose
 
Sapna Pradyuman Patel
Consulting or Advisory Role - Amgen; Genentech/Roche; MD Anderson Cancer Center
Speakers' Bureau - Merck
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Prometheus (Inst); Reata Pharmaceuticals (Inst)
 
Michael J. Overman
No Relationships to Disclose
 
Scott Kopetz
Consulting or Advisory Role - Agendia; Amgen; Array BioPharma; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Merrimack; Roche; Sanofi; Sysmex; Taiho Pharmaceutical
Research Funding - Agendia; Amgen; Biocartis; GlaxoSmithKline; Guardant Health; Roche; Sanofi; Sysmex
 
Mark G. Erlander
Employment - Trovagene
Stock and Other Ownership Interests - Trovagene
Travel, Accommodations, Expenses - Trovagene
 
Vlada Melnikova
Employment - Transgenomic; Trovagene
Travel, Accommodations, Expenses - Trovagene
 
Funda Meric-Bernstam
Honoraria - Genentech; Roche; Sysmex
Consulting or Advisory Role - Genentech; Novartis; Roche
Research Funding - AstraZeneca; Bayer; Calithera Biosciences; Debiopharm Group; Genentech; Novartis; Taiho Pharmaceutical